New antibody targets cancer protein in advanced tumors
Disease control
Recruiting now
This study is testing a new antibody drug called TST001 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the body handles the drug. Researchers will also check if the drug helps shrink t…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC